Infiuss health
Infiuss Health is an AI-powered clinical research platform that streamlines and accelerates clinical studies by automating participant recruitment, study planning, compliance monitoring, and payments. Their flagship product, Probe, integrates all research management tools into one unified platform, reducing time and costs significantly while enhancing productivity and compliance. The company focuses on decentralizing clinical research access, enabling sponsors to run fully remote or hybrid studies with diverse participant cohorts. Infiuss Health also offers an automated global payment gateway for clinical trial payments, improving financial transparency and collaboration worldwide. Their platform is designed to scale studies efficiently and securely, positioning them as a modern solution in clinical research management.
Infiuss health
Infiuss Health is an AI-powered clinical research platform that streamlines and accelerates clinical studies by automating participant recruitment, study planning, compliance monitoring, and payments. Their flagship product, Probe, integrates all research management tools into one unified platform, reducing time and costs significantly while enhancing productivity and compliance. The company focuses on decentralizing clinical research access, enabling sponsors to run fully remote or hybrid studies with diverse participant cohorts. Infiuss Health also offers an automated global payment gateway for clinical trial payments, improving financial transparency and collaboration worldwide. Their platform is designed to scale studies efficiently and securely, positioning them as a modern solution in clinical research management.
TL;DR
Headquarters: San Francisco, California, United States
Product: AI-powered clinical research platform (Probe) and digital patient twins
Focus: Decentralized clinical research (remote/hybrid studies) and automated trial payments
Stage / Funding: Series A (most recent round announced Mar 1, 2025)
Company Overview
Problem Domain
Clinical research management, participant recruitment, decentralized trials, and pharmaceutical simulation via digital patient twins.
Industry
Health technology / Clinical research software
Funding Track Record
Pre-money valuation reported as $18M on funding round profile.
Investor Signal
“Multiple venture investors (reported total of 17 investors across rounds)”